Propanc Biopharma plans to acquire a digital asset finance company with a market capitalization below its net asset value.

Digital asset finance company Propanc Biopharma (NASDAQ: PPCB) announced a strategic plan to acquire digital asset management (DAT) companies whose current market capitalization to net asset value (MNAV) ratio is lower than that of their target companies.